Skip to main content
SpringerLink
Log in

DEX implant intravitreal injection, sustained intraocular hypertension, and steroid-induced glaucoma in patients with no risk factors

Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Cite this article

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Armaly MF (1963) Effects of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol 70:490–499

    Google Scholar 

  2. Dot C, El Chehab H, Russo A et al (2015) Ocular hypertension after intravitreal steroid injections: clinical update as of 2015. J Fr Ophtalmol 38:656–664

    Article  CAS  PubMed  Google Scholar 

  3. Malclès A, Dot C, Vie AL et al. (2016) Safety of intravitreal dexamethasone implants (Ozurdex®): the SAFODEX study. Incidence and Risk factors of Ocular Hypertension. Retina,doi: 10.1097/IAE.0000000000001369

  4. Boyer DS, Yoon YH, Belfort R Jr et al (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121:1904–1914

    Article  PubMed  Google Scholar 

  5. Vie AL, Kodjikian L, Malcles A et al (2016) Tolerance of intravitreal Dexamethasone implants in patients with ocular hypertension or open-angle glaucoma. Retina 37(1):173–178

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Croix-Rousse Teaching Hospital, Hospices Civils de Lyon, 103 Grande rue de la Croix Rousse, 69004, Lyon, France

    Amina Rezkallah, Laurent Kodjikian & Ariane Malclès

  2. Department of Ophthalmology, Desgenettes Military Hospital, 108 boulevard Pinel, 69003, Lyon, France

    Corinne Dot

  3. French Military Health Service Academy, Val de Grâce, Paris, France

    Corinne Dot

Authors
  1. Amina Rezkallah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laurent Kodjikian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ariane Malclès
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Corinne Dot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amina Rezkallah.

Ethics declarations

Funding

No funding was received for this research.

Conflict of interest

Amina Rezkallah, Ariane Malclès, declared no conflicts of interest.

Laurent Kodjikian is a consultant for Alcon, Allergan, Alimera, Bayer, Novartis and Théa.

Corinne Dot is a consultant for Bayer, Alcon, Allergan, and Novartis.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rezkallah, A., Kodjikian, L., Malclès, A. et al. DEX implant intravitreal injection, sustained intraocular hypertension, and steroid-induced glaucoma in patients with no risk factors. Graefes Arch Clin Exp Ophthalmol 256, 219–220 (2018). https://doi.org/10.1007/s00417-017-3773-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-017-3773-z

search

Navigation